SOURCE: Metiscan

April 28, 2009 09:00 ET

Metiscan Subsidiary President & CEO Earns HL7 Certification

DALLAS, TX--(Marketwire - April 28, 2009) - Metiscan, Inc. (PINKSHEETS: MTIZ), a leading provider of products and services that streamline the management of diagnostic imaging facilities, today announced that the President and CEO, Iain Shigeoka, Ph.D., of its wholly owned subsidiary Metiscan Managed Services, Inc. (Managed Services), has earned the Control Specialist Certification for Health Language Seven (HL7) Version 2 standards.

HL7 standards provide for interoperability between electronic health record (EHR) systems that reduce ambiguity, optimize workflow, and enhance knowledge transfer among all stakeholders in digital workflow systems, such as the EHR, RIS and PACs systems that Managed Services currently provides to its diagnostic imaging customers.

Dr. Shigeoka earned this certification shortly after Managed Services became a member of the HL7 International Standards Organization. Being a member of the HL7 International Standards Organization provides Metiscan with access to the standards developed by the HL7 group, as well as the ability to participate in standards creation and voting rights in approving standards. Additional training and certification is planned to ensure that Managed Service employees are properly trained to deploy and manage HL7 compliant systems.

"Obtaining HL7 certification is a key part of our commitment to EHR standards," commented Dr. Shigeoka, President and CEO of Metiscan's wholly owned subsidiary, Metiscan Managed Services, Inc. "It is critical in today's world that our customers can interoperate seamlessly with other electronic health systems. Standards are essential for improving the quality of data exchange while minimizing costs and errors. I believe that the American Recovery and Reinvestment Act of 2009, having $20B earmarked for health information technology, will encourage, if not mandate, physicians to use EHR systems that are compliant with HL7 standards."

Metiscan's embracing of HL7 standards joins its current embracement of DICOMM standard compliant systems. Metiscan's commitment to embrace these standards ensures the broadest support of modalities and external EHR systems.

About Metiscan, Inc.

Metiscan, Inc. is a national provider of products and services that streamline the management and operation functions of diagnostic imaging facilities, radiology groups, in-office imaging groups, small hospitals and physician offices and is an operator of two diagnostic MRI facilities located in Corpus Christi, TX, and Pottsville, PA. Metiscan's keystone product is a web-based radiology information system that interfaces Radiology Information System (RIS), Teleradiology and PACS (Picture Archiving and Communication System) for its clients. Metiscan also provides information management and operations support for diagnostic imaging facilities through complete revenue cycle management, electronic health records or EHR, medical transcription services and functional training as needed.

Safe Harbor Statement: Certain of the statements made in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Such forward-looking statements involve known and unknown risks, uncertainties and other unknown factors that could cause Metiscan's actual results to be materially different from the historical results or from any future results expressed or implied by such forward-looking statements. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements labeled with the terms "believes," "belief," "intends," "anticipates" or "plans" to be uncertain and forward-looking. The Company does not intend to update any of the forward-looking statements after the date of this release to conform these statements to actual results or to changes in its expectations, except as may be required by law.

Contact Information

  • Contact:
    Investor Relations
    David Donlin
    Cervelle Group
    Phone: 407-614-5955